Comparing Olumiant vs Tofacitinib
Olumiant (baricitinib) | Tofacitinib |
|
---|
Olumiant (baricitinib) | Tofacitinib |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Alopecia, Rheumatoid Arthritis, COVID-19. Olumiant may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Ankylosing Spondylitis, Rheumatoid Arthritis, Ulcerative Colitis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis. Tofacitinib may also be used for purposes not listed... View more |
Related suggestions Rheumatoid Arthritis
|
|||||||
More about Olumiant (baricitinib) | More about Tofacitinib | ||||||||
Ratings & Reviews | |||||||||
Olumiant has an average rating of 8.2 out of 10 from a total of 15 ratings on Drugs.com. 87% of reviewers reported a positive effect, while 13% reported a negative effect. |
Tofacitinib has an average rating of 5.7 out of 10 from a total of 175 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Olumiant side effects |
View all Tofacitinib side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Olumiant prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
N/A |
Xeljanz, Xeljanz Oral Solution, Xeljanz XR | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
12.5 hours |
3 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 516 drugs are known to interact with Olumiant:
|
A total of 676 drugs are known to interact with Tofacitinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
May 31, 2018 |
November 06, 2012 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Kenalog-40
Kenalog-40 is a long-acting corticosteroid injection for intramuscular (into the muscle) or ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Zilretta
Zilretta (triamcinolone injection) is used for the management of osteoarthritis pain of the knee ...
Litfulo
Litfulo is used to treat severe alopecia areata to reduce hair loss in adults and adolescents 12 ...
Rogaine
Rogaine (minoxidil) is used to help regrow new, thicker hair and prevent future hair loss in men ...
Leqselvi
Leqselvi (deuruxolitinib) is a JAK inhibitor used for the treatment of severe hair loss (alopecia ...
Azmacort
Azmacort (triamcinolone) is used to prevent asthma attacks. Includes Azmacort side effects ...
Ritlecitinib
Ritlecitinib is used to treat severe alopecia areata in adults and adolescents 12 years and older ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.